Nexplanon REMS

Nexplanon’s duration of use has been extended to 5 years. With that approval, the FDA has mandated the implementation of the Risk Evaluation and Mitigation Strategy (REMS). A REMS is a strategy used by the FDA to manage known or potential risks associated with a product. The implementation of a REMS program for NEXPLANON is to mitigate complications due to improper insertion and removal.

If you are considered an Active Nexplanon-Trained Healthcare Provider, you will need to get certified in REMS for Nexplanon starting on 2/23/2026. 

You must go to the Nexplanon REMS website to achieve this certification by 08/23/2026. The course will close after this date. If you do not complete this certification course by the deadline, you will no longer be considered an active Nexplanon provider, and will have to take the Organon course again, and complete the competency checklist.

Some of you may have received a letter/email to alert you of this requirement; however, I hear a good portion of the clinicians have not received it. Please read the attached letter that one of our clinicians received to gain more knowledge about this certification. If you do not provide this service but know others that do, please spread the word.